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ABSTRACT
Type 2 diabetes mellitus (T2DM) is closely related to inflammation. One of inflammation 
marker in T2DM is monocyte chemoattractant protein-1 (MCP-1). Previous study reported 
that MCP-1 promoter methylation is associated correlated with plasma triglycerides (TG) 
levels in T2DM. Furthermore, some studies stated that TG levels in T2DM can be controlled 
through consumption of diets containing resistant starch. This study aimed to investigate 
the effect of high resistant starch snack on MCP-1 promoter methylation and TG levels 
in T2DM patients. This study was a cross-over trial. A total of 19 T2DM patients have 
been selected with the criteria of fasting blood glucose levels (GDP) >126 mg/dL, aged 
40-60 years, and duration of DM at least 1 year. Subject consume snack as much as 32 
g/day with the resistant starch content are 4.25 g for 4 weeks. Data collection and blood 
sample were taken before and after the intervention. The analysis of MCP-1 promoter 
methylation was performed by methylated specific-PCR (MS-PCR) using DNA samples 
extracted from mononuclear cells, whereas TG levels analysis was performed by the 
enzymatic colorimetric method. Statistic analysis was performed by Fisher exact test for 
methylation data, paired t-test and unpaired t test for TG levels, and Spearman correlation 
test for the correlation between variabels. Methylation result showed that frequency 
of methylated (52.6%) and unmethylated (47.4%) status before and after intervention 
were same (p>0.05). Plasma TG levels after intervention decreased, but not significant 
(p>0.05). The correlation between MCP-1 promoter methylation and plasma TG levels 
was significant (p<0.05). In conclusion, the rich resistant starch snacks intervention 
does not affect MCP-1 promoter methylation changes. This intervention can decrease 
plasma TG levels T2DM patients, although it is not significant.
ABSTRAK
Diabetes melitus tipe 2 (DMT2) berkaitan erat dengan inflamasi sistemik. Salah satu 
penanda inflamasi pada DMT2 adalah monocyte chemoattractant protein-1 (MCP-1). 
Penelitian sebelumnya melaporkan metilasi promotor MCP-1 berkaitan dengan kadar 
trigliserida (TG) plasma pada DMT2. Selain itu, beberapa penelitian menyebutkan bahwa 
kadar TG plasma pada DMT2 dapat dikendalikan dengan diet pati resisten. Penelitian ini 
bertujuan mengkaji pengaruh kue pati resisten tinggi terhadap metilasi promotor MCP-1 
dan kadar TG pada pasien DMT2. Penelitian ini merupakan penelitian sama subjek yang 
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melibatkan 19 penderita DMT2 yang memenuhi kriteria gula darah puasa > 126 mg/mL, 
berumur 40-60 tahun, dan menderita DM paling tidak 1 tahun. Subjek mengkonsumsi 
kue 32 g/hari dengan kandungan pati resisten 4.25 g selama 4 minggu. Data dan sampel 
darah diambil sebelum dan sesudah intervensi. Analisis metilasi promotor MCP-1 dilakukan 
PCR spesifik metilasi menggunkan sampel DNA yang diekstraksi dari sel mononuclear, 
sedangkan analisis kadar TG dilakukan secara enzimatik menggunakan metode kolorimetri. 
Anaaisis statistic dilakukan menggunakan uji Fisher exact untuk data metilasi, uji t 
berpasangan dan tidak berpasangan untuk kadar TG dan uji korelasi Spearman untuk 
hubungan antar variabel. Hasil uji metilasi menunjukkan status metilasi (52.6%) dan tidak 
termetilasi (47.4%) sebelum dan sesudah intervensi tidak berbeda (p>0.05). Kadar TG 
plasma setelah intervensi turun tetapi tidak signifikan (p>0.05). Teradapat hubungan 
yang signifikan antara metilasi promotor MCP-1 dan kadar TG plasma (p<0.05). Dapat 
disimpulkan, intervensi kue kaya pati resisten tidak mempengaruhi metilasi promotor MCP-
1. Intervensi dapat menurunkan kadar TG plasma pasien DMt2 meskipun tidak signifikan.   
Keyword: Type 2 diabetes mellitus - resistant starch - DNA methylation - MCP-1 -  
triglyceride
INTRODUCTION
Diabetes mellitus (DM) is a major health 
problem in the world due to its prevalence 
constantly increases. Type 2 diabetes mellitus 
(T2DM) is a DM type commonly found, at 
least 90% cases.1 The T2DM is characterized 
by high blood glucose levels (hyperglycemia) 
accompanied by impairment of metabolism 
of carbohydrates, lipids, and proteins as a 
result of the body’s cells less responsive to 
insulin or insulin resistance.2 The T2DM is 
caused by the interaction between genetic and 
environment.3
Type 2 diabetes mellitus is closely 
related to inflammatory conditions. One 
of inflammation marker in T2DM is a 
chemokine monocyte chemoattractant 
protein-1 (MCP-1). Regulation of MCP-1 
expression involves several mechanisms. The 
binding of nuclear factor κB (NFκB) in the 
promoter region of MCP-1 is an important 
mechanism for the transcription of MCP-1.4 
Epigenetic modifications are another potential 
mechanism for regulating the expression of 
MCP-1. The previous research showed that 
the MCP-1 promoter methylation correlates 
significantly with the levels of plasma TG in 
T2DM patients. Increased TG can be a factor 
or a result of methylation.5
Triglyceride levels in T2DM patients 
may be controlled through the consumption 
of diets containing resistant starch.6 Some 
studies suggest that resistant starch can 
lowering fasting plasma TG levels.7,8 Short 
chain fatty acid as a fermentation results 
of resistant starch may reduce lipolysis in 
adipose tissue, resulting circulating free fatty 
acids or non-esterified fatty acids (NEFA) 
levels lower. Short chain fatty acids can also 
increase the β-oxidation of TGs in the liver.9 In 
addition, short-chain fatty acids can improve 
insulin sensitivity, so that it can suppress the 
production of hepatic VLDL-TG and lower 
the levels of plasma TG.10
Resistant starch consumption needs of 
each country is different. In Australia with the 
high consumption habits of resistant starch are 
recommended to consume 20 g/day.11 While in 
developing countries, the average consumption 
of resistant starch ranged between 3-7 g/day.12 
This study used the intervention snacks with 
resistant starch content to be consumed per 
day are 4.25 g (Sunarti et al., Unpublished). 
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Based on the explanation above, it was 
assumed that foods high in resistant starch 
can increase MCP-1 promoter methylation as 
well as reducing TG levels in T2DM patients. 
Increased methylation of MCP-1 can suppress 
the expression of this gene. Therefore, this 
condition is expected to prevent the vascular 
complications in T2DM patients.
MATERIALS AND METHODS
Subjects
This study involved 19 T2DM patients 
from Dr. Sardjito General Hospital, 
Yogyakarta with the inclusion criteria were 
fasting blood glucose (FBG) >126 mg/dL, 
aged 40-60 years, and duration of DM at least 
1 year. Patients with T2DM were smokers, 
pregnant, lactating were excluded from this 
study. Subject consume snack as much as 
32 g/day with the resistant starch content 
are 4.25 g for 4 weeks. Data collection and 
blood sampling were conducted before and 
after the intervention. Data collected with 
anthropometric measurements included body 
weight and height. Blood samples were used 
to analyze the biochemical parameters (fasting 
blood glucose and TGs) and epigenetic 
(MCP-1 promoter methylation). This study 
was approved by the Medical and Health 
Research Ethics Committee of the Faculty 
of Medicine, Public Health and Nursing, 
Universitas Gadjah Mada and the Education 
and Research Section, Dr. Sardjito General 
Hospital, Yogyakarta.
Biochemical examinations
Fasting blood was collected in EDTA 
tubes for further separated into blood plasma 
and buffy coat. Blood plasma was used for 
FBG examination using the glucose oxydase-
p-amino phenazone (GOD-PAP) method and 
for TGs examination using the enzymatic 
colorimetric methods by gliserol-3-fosfat-
oksidase (GPO) (DiaSys Kit). Buffy coat was 
used for MCP-1 methylation analysis.
Gene promoter methylation analysis of 
MCP-1
The MCP-1 methylation analysis was 
performed by MS-PCR method. Isolation of 
peripheral blood mononuclear cells (PBMC) 
was performed by using Ficoll solution, then 
the DNA was extracted from mononuclear cells 
using Wizard® Genomic DNA Purification Kit 
(Promega). DNA concentration was measured 
using a Nano Vue Plus, then performed with 
EZ DNA bisulfite conversion methylation 
TM Kit (Zymo Research). Furthermore, the 
amplification was done by using two pairs 
of primers, which were as follows: U-F 5’-
GTG GTT GTT TAA TGA GGT AGG AGT-
3 ‘and 5’-TAA U-R AAA AAA AAA AAA 
AAT ACA CAA AAC A-3’; M-F 5’-TGG 
TTT AAG TTG GTA GGT GAA GC-3 ‘and 
5’-M-R AAC AAA AAA AAA AAA AAA 
CGAA TCA-3’ with the product size 234 bp 
and 228 bp. The CpG sequences located in 
the promoter region of 2890-3050 bp. The 
conditions of PCR cycle were: 1 cycle of 95 
°C for 5 min, 35 cycles of 95 °C for 1 min, 
60 °C (for methylated primer) and 62 °C (for 
unmethylated primer) for 1 min, 72 °C for 1 
min followed by a 10-min extension at 72 °C. 
The PCR products were run on 1.5% ethidium 
bromide-stained agarose gel electrophoresis.
Statistical analysis
Normality of data was tested by Saphiro-
wilk. Numeric variables were presented as 
mean values and standard deviation (SD), 
while categorical data were presented as 
percentage. Normal distribution data were 
analyzed using dependent sample t-test for 
variables between groups and independent 
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sample t-test for variables in a group. Log 
transformed data which still not normal 
was computed using Mann Whitney test. 
Methylation pattern was classified into two 
categories (methylated 1, unmethylated 2). 
Methylation data were compared by Fisher 
exact test. Correlation between variables were 
analyzed using Spearman test. A p value <0.05 
was considered statistically significant. 
RESULTS
Characteristics of subjects
TABLE 1 shows the characteristics of 
subjects of this study. A total of 19 subjects 
with 9 male dan 10 female were involved in 
this study. These subjects had average age 
53 years old with the DM duration were 7 
years. These T2DM subjects have had a mean 
fasting blood glucose 169.01 mg/dL and mean 
TG levels of 144.19 mg/dL.
TABLE 1. Characteristics of subjects (n=19)
Characteristics of subject (n= 19) Mean ± SD
Age (year) 53.32 ± 3.35
Duration of DM (year) 7.16 ± 6.03
Gender
- Male [n (%)] 9 (47.4)
- Female [n (%)] 10 (52.6)
Height (cm) 158.67 ± 1.66
Weight (kg) 72.88 ± 1.24
BMI (kg/m2) 27.54 ± 1.13
FBG (mg/dL) 169.01 ± 59.48
TG (mg/dL) 144.19 ± 55.19
Note: BMI: body mass index; FBG: fast blood glucose; TG: 
triglyceride
The change of parameters
TABLE 2 shows that mean of body weight, 
BMI, and FBG levels after the intervention 
were lower than before the intervention or 
decrease. However, it was not significant 
statistically (p>0.05). Mean of TG levels after 
the intervention was also decrease, but it was 
not also significant statistically (p>0.05). 
TABLE 2. The changes of parameters before and after intervention
Parameters Pre-intervention Post-intervention p*
Height (cm) 160.00 ± 8.19 159.86 ± 8.52 0.518
Weight (kg) 69.87 ± 9.36 69.45± 9.08 0.070
BMI (kg/m2) 27.33 ± 3.39 27.22 ± 3.34 0.359
FBG levels (mg/dL) 169.01 ± 59.48 159.77 ± 51.23 0.184
TG levels (mg/dL) 144.19 ± 55.19 129.28 ± 56.67 0.059
Data distribution was tested using Saphiro-Wilk test. Data was presented as mean ± SD. 
BMI: body mass index; FBG: fasting blood glucose; TG: triglyceride.  *Dependent sample 
t-test, p< 0.05 statistically significant
Distribution of MCP-1 promoter 
methylation status
FIGURE 1 shows images of several 
representative of MCP-1 promoter methylation 
pre- and post-intervention. The presence of a 
visible product in the M lanes indicates the 
presence of methylated CpG islands (228 bp). 
The presence of product in U lanes indicates 
the presence of unmethylated CpG islands 
(234 bp). 
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TABLE 3. Distribution of MCP-1 promoter methylation status
Status Pre-intervention [n (%)]
Post- intervention
[n (%)] p* OR (95% CI)
Methylated 9 (47.4%) 9 (47.4%)
1.000 1.00 (0.28-3.57)
Unmethylated 10 (52.6%) 10 (52.6%)
Data are presented as number (%). Variables between pre- and post- intervention group were compared by 
Fisher Exact test. OR: odds ratio; CI: confidence interval. *Fisher exact test, p< 0.05 statistically significant
FIGURE 1. Images are several representative of MCP-1 promoter methylation in groups (a) pre-
intervention, (b) post-intervention. M: methylation primer; U: unmethylation primer.
Tabulation of MCP-1 promoter 
methylation status distribution are presented 
in TABLE 3. This TABLE shows that 
frequency of methylated and unmethylated 
status of MCP-1 promoter methylation before 
and after the intervention were same, so there 
was no significant difference (p>0.05). But the 
percentage of status unmethylated (52.6%) 
higher than methylated (47.4%), before and 
after intervention. 
TABLE 4.  Plasma TG levels between MCP-1 promoter methylation and 
unmethylation
Methylation status
p
Methylated Unmethylated
TG levels (mg/dL) 119.34 ± 52.20 153.65 ± 54.74 0.056*
Data distribution was tested using Saphiro-Wilk test. Data was presented as mean ± SD. 
*Independent t-test, p< 0.05 statistically significant. TG: triglyceride
Correlation between MCP-1 promoter 
methylation status and plasma TG levels 
The plasma TG levels of T2DM patients 
with MCP-1 promoter unmethylation were 
higher than those with MCP-1 promoter 
methylation (TABLE 4). However, it was not 
significant statistically (p>0.05). 
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A significant correlation between MCP-
1 promoter methylation and plasma TG 
levels was observed (p<0.05), although this 
correlation was weak (r= 0.322) (TABLE 5). 
TABLE 5.  Correlation between MCP-1 promoter 
methylation and plasma TG levels
Methylation Status
TG levels (mg/dL)
r 0.322
p 0.049*
N 38
* Spearman correlation test, p < 0.05 statistically significant; TG: 
triglyceride
Snack intake during intervention
The mean of snack intake per day of 
subjects are 30.77 g. A total snack that must be 
consumed everyday for intervention time (4 
weeks) are 32 g, so the compliance of subjects 
were 96.16% (TABLE 6). 
TABLE 6. Snack intake per day
Classification Mean ± SD Min-Max
Male (n = 9) 30.67 ± 1.59 27.43 – 32.00
Female (n = 10) 30.73 ± 0.90 29.72 – 32.00
Total 30.77 ± 1.25 27.43 – 32.00
The mean of resistant starch intake from 
snack per day of subjects are 4.08 g. This 
amounts still not fulfill the resistant starch 
content determined to consume per day, that 
were 4.25 g (TABLE 7).
TABLE 7.  Mean of nutrients intake from snack 
per day
Nutrients Mean ± SD
Energy (kcal) 142.95 ± 5.82
Protein (g) 0.93 ± 0.04
Fat (g) 5.61 ± 0.23
Carbohydrate (g) 20.15 ± 0.82
Dietary fiber (g) 0.82 ± 0.03
Resistant starch (g) 4.08 ± 0.17
DISCUSSION
No change in methylation status after the 
intervention was observed in this study. This 
estimated that the intervention snack affect the 
MCP-1 promoter methylation yet. However, it 
needs further study to prove this reason because 
there was no literature suggest the duration 
of resistant starch dietary interventions that 
affect the epigenetic profile. The research 
about effect of diet on MCP-1 epigenetic 
profile was performed in animal model with 
methionine supplementation. This study was 
performed in mice with a apoliportotein E 
deficiency (ApoE-/-) which induced with high 
methionine diet for 15 weeks. The results 
showed the hypomethylation of MCP-1 
promoter region significantly. It is estimated 
as an effect of decreasing activity of nuclear 
factor-κB (NFκB)/DNA methyltransferase 
1 (DNMT1). However, the duration of 
methionine induction and resistant starch is 
known to have the same time to influence the 
MCP-1 methylation yet.13
The higher frequency of unmethylated 
status than methylated status associated with 
the glycemia condition. Hyperglycemia leads 
to increased production of reactive oxygen 
species (ROS) that is associated with increased 
DNA damage and chromosomal degradation 
with alteration of hypomethylation of the 
DNA.14 Chronic increase of ROS in the cells 
can also result in lipid peroxidation and 
generation of a wide range of other reactive 
products with the potential to damage DNA.15 
Such DNA lesion shave been shown to 
interfere with the ability of DNA to function 
as a substrate for the DNA methyltransferases, 
result in global hypomethylation.16
The not significantly decrease in TG 
levels was probably caused by the lack of 
resistant starch content in snack that consume 
of subject. Subject just consumed 4.08 g/day 
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of resistant starch in this study. This amounts 
still not fulfill the resistant starch content 
determined to consume per day, that are 
4.25 g. This value was not differ so far from 
determined value. However, TG levels may 
decrease significantly if the subjects have a 
100% compliance.
Decreasing of TG levels after the 
intervention was estimated caused by resistant 
starch content in the snack. Mechanism of 
decreasing TG levels by resistant starch 
is caused by the physiological function of 
SCFA. These SCFA may decreased lipolysis 
of adipose tissue, then decreasing free fatty 
acid circulation (FFA) or non-esterified 
fatty acids (NEFA).9 Low of free fatty acid 
circulation may decreased TG hepatic and 
decreased the secretion of VLDL, so it can 
control the increasing of plasma TG levels.17,18 
Short chain fatty acid may improve the 
insulin sensitivity, then inhibit lipolysis of 
adipose tissue and decreasing TG levels in 
circulation.10 This SCFA may also improve 
the fatty acid oxidation in the liver through 
the elevation of forkhead transcription factor 
(Foxa2), PPAR–G coactivator β (PGC-1β), 
and PPAR-α gene expression.9
The results of Spearman correlation test 
showed that the correlation between MCP-
1 promoter methylation and TG levels was 
statistically significant. Mechanism about the 
correlation between methylation of MCP-1 
and TG levels are still unknown. However, 
there are two approaches that may explain 
about this correlation. First, peroxisome 
proliferator activated receptor (PPAR) 
activation can inhibit hypermethylation of the 
inducible nitric oxide synthase (iNOS) gene 
which implies that fatty acids or TG which 
is one PPAR ligand could impose epigenetic 
modifications on critical genes participating in 
atherogenesis. One of this genes is MCP-1.19 
Second, down-regulation of the S-adenosyl-
homocysteine  hydrolase (SAH1) expression 
in yeast leads to accumulation of S-adenosyl-
L-homocysteine (AdoHcy) and decreasing de 
novo synthesis of phosphatidylcholine in vivo. 
This decrease followed by an increase in TG 
levels, demonstrating that SAH1 regulated 
methylation has a major impact on cellular 
lipid homeostasis.20
CONCLUSION
The rich resistant starch snacks 
intervention does not affect MCP-1 promoter 
methylation changes significantly. However, 
this intervention can decrease plasma TG 
levels, although it is not significant. In 
addition, the correlation between plasma 
TG levels and MCP-1 promoter methylation 
status are statistically significant.
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